Table 2:
Video directly observed therapy usage: percentage of days buprenorphine ingestion confirmed with videos (n=14)
| Medication Adherence | All Participants (n=14) | Completed Per Protocol (n=12)* | ||||
|---|---|---|---|---|---|---|
| Range | Median (IQR) | Mean (SD) | Range | Median (IQR) | Mean (SD) | |
| # of Days with a video submission | 0–27 | 20.5 (14.0 – 24.0) | 17.7 (8.5) | 5–27 | 22.5 (17.8–24.0) | 20.1 (6.4) |
| % of Days with a video submission | 0–96.4% | 73.2% (50.0, 85.7) | 63.3% (30.4%) | 17.9–96.4% | 80.4% (63.4–85.7%) | 71.7% (22.7%) |
| # of Days with self-reported dosing | 4–28 | 27 (21.3, 28) | 22.6 (8.0) | 15–28 | 27 (25–28) | 25.4 (4.1) |
| % of Days with self-reported dosing | 14.3–100% | 96.4% (75.9,100) | 80.9% (28.6) | 53.6–100% | 96.4% (89.3–100%) | 90.8 (14.5%) |
Excludes one participant who was incarcerated for two weeks and one participant unable/unwilling to upload videos